کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5855979 | 1562126 | 2016 | 8 صفحه PDF | دانلود رایگان |

- UP446 is a botanical composition of Scutellaria baicalensis and Acacia catechu.
- UP446 has been used as an active ingredient in joint care dietary supplements and a prescription medical food.
- Effects of UP446 on respiratory, cardiovascular and central nervous systems were assessed in beagle dogs and rats.
- A Functional observational battery, whole body plethysmography system, and implanted telemetry were utilized.
- UP446 showed minimal or no pharmacotoxicological effect on the respiratory, cardiovascular and central nervous systems.
Extensive safety evaluation of UP446, a botanical composition comprised of standardized extracts from roots of Scutellaria baicalensis and heartwoods of Acacia catechu, has been reported previously. Here we carried out additional studies to assess the effect of UP446 on respiratory, cardiovascular and central nervous (CNS) systems. A Functional observational battery (FOB) and whole body plethysmography system in rats and implanted telemetry in dogs were utilized to evaluate the potential CNS, respiratory and cardiovascular toxicity, respectively. UP446 was administered orally at dose levels of 800, 2000 and 5000Â mg/kg to SpragueDawley rats and at 4 ascending dose levels (0, 250, 500 and 1000Â mg/kg) to beagle dogs. No abnormal effects were observed on the cage side, open field, hand held, and sensori-motor observations suggestive of toxicity in respiratory, cardiovascular and central nervous (CNS) systems. Rectal temperatures were comparable for each treatment groups. Similarly, respiratory rate, tidal volume and minute volume were unaffected by any of the treatment groups. No UP446 related changes were observed on blood pressure, heart rate and electrocardiogram in beagle dogs at dose levels of 250, 500 and 1000Â mg/kg. Some minor incidental, non-dose correlated changes were observed in the FOB assessment. These data suggest that UP446 has minimal or no pharmaco-toxicological effect on the respiratory, cardiovascular and central nervous systems.
Journal: Regulatory Toxicology and Pharmacology - Volume 77, June 2016, Pages 184-191